Lanka president hits out at committee probing Easter Sunday attacks

Agencies
June 8, 2019

Colombo, Jun 8: Sri Lankan President Maithripala Sirisena has publicly taken to task the parliamentary select committee on the Easter Sunday jihadi attacks, saying he was opposed to top officials testifying on national security matters before the media.

Sirisena's outburst is set to trigger another conflict between him the executive and parliament the legislature, analysts said.

Sirisena on Friday called for an emergency Cabinet meeting and said he stand opposed to the Parliamentary Select Committee (PSC) probing the attacks summoning intelligence officers and disclosing intelligence information to the media.

"I am completely opposed to senior intelligence officers being questioned openly in parliament. This exposes very sensitive national security information," Sirisena said.

Among the officials questioned so far are the Defence Secretary, intelligence chief, police chief and former defence secretary.

The president said that those who have appeared before the PSC so far are former officers or officials and not current officers and have revealed key information. 

The then police chief Pujith Jayasundera, who was sent on compulsory leave, told the PSC that he had been overlooked by Sirisena for security council meetings. Sirisena was dealing with the head of the State Intelligence Service, overlooking Jayasundera. 

Hemasiri Fernando, the defence ministry secretary sacked by Sirisena for his failure to prevent the April 21 attacks, said the intelligence on a possible jihadi attack had not been given due importance at the security council meetings.

Other unimportant matters discussed while no action plan was ever discussed on the jihadi threat.

He said that he will not allow any current officer to be summoned before the PSC and that his stand has been communicated to the Cabinet.

"This is not done anywhere in the world - key intelligence officers being openly questioned in front of the media," Sirisena said. 

"They can become targets of criminals as their identities have been revealed." Sirisena's discomfiture stems from the fact that Sirisena as the Minister of Defence was responsible for the intelligence failure which led to inaction despite the availability of prior warnings on the Easter Sunday attacks.

The aim of the emergency Cabinet meeting was to discuss what he termed the damage caused to the national security by the PSC proceedings. 

The cabinet meeting, however, ended without any agreement.

Sirisena on June 4 wrote to Speaker Karu Jayasuriya asking him to stop the PSC proceedings. The legislature hit back saying that executive must not interfere in its business. 

This situation is similar to when Sirisena suspended parliament in October last year after he had unconstitutionally named Mahinda Rajapaksa as the prime minister. 

The unprecedented clash between the executive and the legislature lasted nearly 3 months before the highest court in a landmark judgment ended the stalemate forcing Sirisena to restore the status quo. 

A string of powerful blasts tore through three churches and as many luxury hotels, killing 258 people and injuring more than 500 others.

The Islamic State has claimed the attacks, but the government has blamed local Islamist extremist group National Thawheed Jamaath (NTJ) for the bombings.

A total of 106 suspects, including a Tamil medium teacher and a school principal, have been arrested in connection with the blasts.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
June 28,2020

Paris, Jun 28: More than 10 million cases of the new coronavirus have been officially declared around the world, half of them in Europe and the United States, according to an AFP tally on Sunday based on official sources.

At least 10,003,942 infections, including 498,779 deaths, have been registered globally.

Europe remains the hardest hit continent with 2,637,546 cases including 195,975 fatalities, while the United States has 2,510,323 infections including 125,539 deaths.

The rate of infections worldwide continues to rise, with one million new cases recorded in just six days.

The tallies, using data collected by AFP from national authorities and information from the World Health Organization (WHO), probably reflect only a fraction of the actual number of infections.

Many countries are testing only symptomatic or the most serious cases and some do not have the capacity to carry out widescale testing.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
June 25,2020

Islamabad, Jun 25: The coronavirus cases in Pakistan crossed the 192,000-mark after 4,044 new Covid-19 infections were detected in the last 24 hours, the health ministry said on Thursday.

According to the Ministry of National Health Services, 148 more people died due to the deadly virus in the country, taking the death toll to 3,903.

With the detection of 4,044 new cases in the last 24 hours, the coronavirus tally in the country now stands at 192,970, it said.

Sindh reported a maximum number of 74,070 infections, followed by 71,191 in Punjab, 23,887 in Khyber-Pakhtunkhwa, 11,710 in Islamabad, 9,817 in Balochistan, 1,365 in Gilgit-Baltistan and 930 in Pakistan-occupied Kashmir.

A total of 81,307 patients have recovered so far from the disease.

Health authorities have so far conducted 1,171,976 coronavirus tests, including 21,835 in the last 24 hours.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.